(Q36021635)

English

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

scientific article

Statements

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors (English)
Alexander N Starodub
Allyson J Ocean
Michael J Guarino
Vincent J Picozzi
Sajeve S Thomas
Serengulam V Govindan
Pius P Maliakal
William A Wegener
Steven A Hamburger
Robert M Sharkey
David M Goldenberg

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit